Finance

Lists
Why is NVCT up 17,74%?
Dive Deeper
NVCT:NASDAQ
Nuvectis Pharma Inc
20,91 $
+17,74%
(+3,15) 1D
21,00 $
+0,43% (+0,090)
After hours
Closed: 6 қар., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVCT...
Open
18,01 $
High
21,05 $
Low
17,80 $
Mkt. cap
681,28 млн
Avg. vol.
186,16 м.
Volume
258,70 м.
52-wk high
29,28 $
52-wk low
5,55 $
EPS
-1,89 $
Beta
-0,21
Shares outstanding
34,39 млн
No. of employees
16
Open
18,01 $
High
21,05 $
Low
17,80 $
Mkt. cap
681,28 млн
Avg. vol.
186,16 м.
Volume
258,70 м.
52-wk high
29,28 $
52-wk low
5,55 $
EPS
-1,89 $
Beta
-0,21
Shares outstanding
34,39 млн
No. of employees
16
News stories
From web sources and news partners
About Nuvectis Pharma Inc
CEO-
Employees16
Founded2020
HeadquartersФорт Ли, Нью-Джерси, Америка Құрама Штаттары
SectorHealth Care
Industry-
Analyst ratings
Based on 3 analysts giving stock ratings to NVCT in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NVCT in the last 3 months.
Highest
Current 20,91 $
39,00 $ (+86,51%)
Average
34,50 $ (+64,99%)
Lowest
30,00 $ (+43,47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
30,00 $
+43,5%
11/04/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
39,00 $
+86,5%
11/04/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Initiated
-
-
08/24/2026
Christopher Liu
Lucid Capital
Buy
Maintained
34,00 $
+62,6%
08/05/2026
Jonathan Aschoff
Roth MKM
Buy
Reiterated
33,00 $
+57,8%
07/06/2026
Unknown Analyst
Roth MKM
Buy
Maintained
20,00 $
-4,4%
06/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5,09 млн
4,11 млн
4,68 млн
27,37 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,53 млн
2,15 млн
2,51 млн
3,68 млн
Operating expense
7,62 млн
6,26 млн
7,20 млн
31,05 млн
Total operating expenses
7,62 млн
6,26 млн
7,20 млн
31,05 млн
Operating income
-7,62 млн
-6,26 млн
-7,20 млн
-31,05 млн
Other non operating income
-
-
-
979,00 м.
EBT including unusual items
-7,31 млн
-6,05 млн
-7,02 млн
-30,07 млн
EBT excluding unusual items
-7,31 млн
-6,05 млн
-7,02 млн
-30,07 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,31 млн
-6,05 млн
-7,02 млн
-30,07 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
303,00 м.
210,00 м.
177,00 м.
-
Interest expense
-
-
-
-
Net interest expenses
303,00 м.
210,00 м.
177,00 м.
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары